Cargando…
Pharmacoinformatics elucidation of potential drug targets against migraine to target ion channel protein KCNK18
Migraine, a complex debilitating neurological disorder is strongly associated with potassium channel subfamily K member 18 (KCNK18). Research has emphasized that high levels of KCNK18 may be responsible for improper functioning of neurotransmitters, resulting in neurological disorders like migraine....
Autores principales: | Sehgal, Sheikh Arslan, Hassan, Mubashir, Rashid, Sajid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038526/ https://www.ncbi.nlm.nih.gov/pubmed/24899801 http://dx.doi.org/10.2147/DDDT.S63096 |
Ejemplares similares
-
Pharmacoinformatics, Adaptive Evolution, and Elucidation of Six Novel Compounds for Schizophrenia Treatment by Targeting DAOA (G72) Isoforms
por: Sehgal, Sheikh Arslan
Publicado: (2017) -
Pharmacoinformatic and molecular docking studies reveal potential novel antidepressants against neurodegenerative disorders by targeting HSPB8
por: Sehgal, Sheikh Arslan, et al.
Publicado: (2016) -
In silico elucidation of potential drug targets against oxygenase domain of Human eNOS Dysfunction
por: Malik, Abbeha, et al.
Publicado: (2023) -
2-Aminoethoxydiphenyl borate activates the mechanically gated human KCNK channels KCNK 2 (TREK-1), KCNK 4 (TRAAK), and KCNK 10 (TREK-2)
por: Beltrán, Leopoldo, et al.
Publicado: (2013) -
Functional analysis of missense variants in the TRESK (KCNK18) K(+) channel
por: Andres-Enguix, Isabelle, et al.
Publicado: (2012)